An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy

As hematopoietic progenitors supply a large number of blood cells, therapeutic strategies targeting hematopoietic progenitors are potentially beneficial to eliminate unwanted blood cells, such as leukemic cells and immune cells causing diseases. However, due to their pluripotency, targeting those ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Yuta, Kanayama, Masashi, Shen, Zhongchuzi, Kai, Masayuki, Kawamura, Shunsuke, Akiyama, Megumi, Yamamoto, Masahide, Nagao, Toshikage, Okada, Keigo, Kawamata, Norihiko, Toyota, Shigeo, Ohteki, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937628/
https://www.ncbi.nlm.nih.gov/pubmed/33692791
http://dx.doi.org/10.3389/fimmu.2021.618081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937628/
https://www.ncbi.nlm.nih.gov/pubmed/33692791
http://dx.doi.org/10.3389/fimmu.2021.618081

Ejemplares similares